1. Stem cell autocrine CXCL12/CXCR4 stimulates invasion and metastasis of esophageal cancer
   Xingwei Wang et al, 2017, Oncotarget CrossRef
2. CRISPR-mediated reversion of oncogenic KRAS mutation results in increased proliferation and reveals independent roles of Ras and mTORC2 in the migration of A549 lung cancer cells
   Alyssa N. Werner et al, 2023, Molecular Biology of the Cell CrossRef
3. Chemokines and their receptors in lung cancer progression and metastasis
   Zeng-hui Cheng et al, 2016, Journal of Zhejiang University-SCIENCE B CrossRef
4. PD-L1+ lung cancer stem cells modify the metastatic lymph-node immunomicroenvironment in nsclc patients
   A. Raniszewska et al, 2021, Cancer Immunology, Immunotherapy CrossRef
5. Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancy
   Daniel Kaemmerer et al, 2015, Oncotarget CrossRef
6. Hesperidin suppresses the migration and invasion of non-small cell lung cancer cells by inhibiting the SDF-1/CXCR-4 pathway
   Rongmu Xia et al, 2018, Life Sciences CrossRef
7. JMJD3 promotes the epithelial‑mesenchymal transition and migration of glioma cells via the CXCL12/CXCR4 axis
   Shuang Zou et al, 2019, Oncology Letters CrossRef
8. Immunomodulatory Molecules On Lung Cancer Stem Cells From Lymph Nodes Aspirates
   Agata Raniszewska et al, 2020, Cancers CrossRef
9. The CXCL12-CXCR4 Signaling Axis Plays a Key Role in Cancer Metastasis and is a Potential Target for Developing Novel Therapeutics against Metastatic Cancer
   Ping Yang et al, 2020, Current Medicinal Chemistry CrossRef
10. Isorhamnetin, the active constituent of a Chinese herb Hippophae rhamnoides L, is a potent suppressor of dendritic-cell maturation and trafficking
    Hui Shi et al, 2018, International Immunopharmacology CrossRef
11. Targeting CXCR4 and FAK reverses doxorubicin resistance and suppresses invasion in non-small cell lung carcinoma
    Miodrag Dragoj et al, 2017, Cellular Oncology CrossRef
12. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner
    Songping Xie et al, 2017, Oncology Reports CrossRef
13. CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer
    Zhenbo Tu et al, 2017, International Journal of Oncology CrossRef
14. Ribosome induces transdifferentiation of A549 and H-111-TC cancer cell lines
    Mohammad Badrul Anam et al, 2021, Biochemistry and Biophysics Reports CrossRef
15. Combination Treatment with All-Trans Retinoic Acid Prevents Cisplatin-Induced Enrichment of CD133+ Tumor-Initiating Cells and Reveals Heterogeneity of Cancer Stem Cell Compartment in Lung Cancer
    Massimo Moro et al, 2015, Journal of Thoracic Oncology CrossRef
16. Chemokines and Bone
    Annette Gilchrist et al, 2015, Clinical Reviews in Bone and Mineral Metabolism CrossRef
17. Identification of an Unfavorable Immune Signature in Advanced Lung Tumors from Nrf2-Deficient Mice
    Di Zhang et al, 2018, Antioxidants & Redox Signaling CrossRef